tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR

Nektar Therapeutics (NKTR) Balance Sheet

1,166 Followers

Nektar Therapeutics Balance Sheet

Nektar Therapeutics's total assets for Q4 2023 were $398.03M, a decrease of -10.00% from the previous quarter. NKTR total liabilities were $267.05M for the fiscal quarter, a -5.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 398.03M$ 710.60M$ 1.12B$ 1.54B$ 1.98B
Total Liabilities
$ 267.05M$ 343.96M$ 437.68M$ 461.47M$ 571.97M
Total Equity Gross Minority
$ 130.99M$ 366.64M$ 679.51M$ 1.08B$ 1.41B
Total Capitalization
$ 229.50M$ 479.47M$ 679.51M$ 1.08B$ 1.41B
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 150.29M$ 155.25M
Currency in USD

Nektar Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis